<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615470</url>
  </required_header>
  <id_info>
    <org_study_id>MISP53380</org_study_id>
    <nct_id>NCT02615470</nct_id>
  </id_info>
  <brief_title>Enhancing a Sustainable Pharmacy-based Immunization Program in Two States</brief_title>
  <official_title>Impact of a Multicomponent Immunization Intervention on Pneumococcal and Herpes Zoster Vaccinations: A Randomized Controlled Trial of Community Pharmacies in 2 States</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Auburn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Keck Graduate Institute of Claremont, California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Auburn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study's aim is to enhance current immunization activities in community pharmacies through
      targeting the two most commonly available non-seasonal vaccines in community pharmacies,
      namely pneumococcal and herpes zoster vaccination services. The study will compare the change
      in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy from
      the corresponding 6-month period prior to the intervention to the 6-month intervention period
      between intervention pharmacies and the control pharmacies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Community pharmacies are in a unique position and have potential to help increase
      immunization rates, especially among those who do not visit their primary care provider
      regularly. This study seeks to increase the level of pharmacy-based immunization delivery.

      The study intervention is designed to increase the current level of pharmacy-based
      immunization delivery and foster practice change to sustain the intervention effect. Our
      intervention combines evidence-based strategies for improving immunization coverage and
      strategies to overcome system barriers to increase sustainability of the intervention over
      time. The study will focus on pneumococcal and herpes zoster vaccination services.

      Specific aims include:

        1. To compare the change in the number of pneumococcal and herpes zoster vaccinations
           administered in pharmacy from the corresponding 6-month period prior to the intervention
           to the 6-month intervention period between intervention pharmacies and the control
           pharmacies. The pre-intervention period will correspond to the intervention period.

        2. To compare the extent of immunization activity implementation during the intervention
           period between intervention pharmacies and control pharmacies.

        3. To compare the level of sustainability of immunization services over the period of 6
           months after the intervention period ends between the intervention group and the control
           group.

        4. To explore facilitators and barriers to implementing immunization services.

        5. To explore factors affecting patient acceptance of pharmacist's vaccine recommendations
           within the intervention pharmacies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Herpes Zoster and Pneumococcal Vaccinations Administered</measure>
    <time_frame>6 months</time_frame>
    <description>The change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy during the 6-month intervention period from the 6-month baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Strategies Implemented to Promote Immunization Activities</measure>
    <time_frame>6 months</time_frame>
    <description>During the study, pharmacist-technician pairs engaged in on-going strategies used to advertise, market and assess non-seasonal immunization service processes. Of the total of 10 strategies possible, each pair selected strategies that they implemented. Results were reported by a representative from each pharmacy unit.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The Level of Sustainability of Immunization Services</measure>
    <time_frame>24 months</time_frame>
    <description>Change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy from 12 Months Pre- to 12 Months Post-Intervention. A representative of each pharmacy unit reported vaccine doses.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Herpes Zoster</condition>
  <condition>Pneumococcal Infections</condition>
  <arm_group>
    <arm_group_label>Enhanced immunization delivery model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immunization update</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced immunization delivery model</intervention_name>
    <description>Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.</description>
    <arm_group_label>Enhanced immunization delivery model</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Immunization update</intervention_name>
    <description>Basic immunization update online webinar will summarize changes in immunization schedules.</description>
    <arm_group_label>Enhanced immunization delivery model</arm_group_label>
    <arm_group_label>Immunization update</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alabama and California community pharmacies

          -  Must provide in-store prescription-dispensing service

          -  Must provide pneumococcal vaccine and/or herpes zoster

        Exclusion Criteria:

          -  Must have no plan to close or change the ownership in the next 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salisa C Westrick, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Auburn University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Auburn University</name>
      <address>
        <city>Auburn</city>
        <state>Alabama</state>
        <zip>36830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keck Graduate Institute School of Pharmacy</name>
      <address>
        <city>Claremont</city>
        <state>California</state>
        <zip>91711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>November 19, 2015</study_first_submitted>
  <study_first_submitted_qc>November 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <results_first_submitted>May 30, 2018</results_first_submitted>
  <results_first_submitted_qc>July 11, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 20, 2019</results_first_posted>
  <last_update_submitted>July 11, 2019</last_update_submitted>
  <last_update_submitted_qc>July 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Auburn University</investigator_affiliation>
    <investigator_full_name>Salisa Westrick</investigator_full_name>
    <investigator_title>Professor of Health Outcomes Research and Policy</investigator_title>
  </responsible_party>
  <keyword>Pneumococcal Vaccines</keyword>
  <keyword>Shingles</keyword>
  <keyword>Pharmacy</keyword>
  <keyword>Vaccine</keyword>
  <keyword>Immunization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumococcal Infections</mesh_term>
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 27, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT02615470/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 27, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT02615470/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Community pharmacies in Montgomery, Jefferson, Mobile, Tuscaloosa, Lee (AL) and San Bernadino, Riverside, Los Angeles, San Diego in CA were identified using Hayes Directory. Pharmacies were recruited via telephone with a maximum of 5 contact attempts. Eligible pharmacies must offer at least pneumococcal or herpes zoster vaccination service.</recruitment_details>
      <pre_assignment_details>A randomized block design was used. Eligible community pharmacies within each block (AL and CA) were randomly assigned to each treatment group. Pharmacies with the same ownership were assigned to the same treatment group to prevent potential contamination.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Enhanced Immunization Delivery Model</title>
          <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.
Enhanced immunization delivery model: Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
        </group>
        <group group_id="P2">
          <title>Immunization Update</title>
          <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed the Baseline Surveys</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Enhanced Immunization Delivery Model</title>
          <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.
Enhanced immunization delivery model: Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
        </group>
        <group group_id="B2">
          <title>Immunization Update</title>
          <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="58"/>
            <count group_id="B2" value="62"/>
            <count group_id="B3" value="120"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>Pharmacy</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age information was not collected per protocol specifications</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="58"/>
                <count group_id="B2" value="62"/>
                <count group_id="B3" value="120"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="30"/>
                <count group_id="B2" value="32"/>
                <count group_id="B3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Age information was not collected per protocol specifications</measurement>
                    <measurement group_id="B2" value="NA">Age information was not collected per protocol specifications</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Age information was not collected per protocol specifications</measurement>
                    <measurement group_id="B2" value="NA">Age information was not collected per protocol specifications</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Age information was not collected per protocol specifications</measurement>
                    <measurement group_id="B2" value="NA">Age information was not collected per protocol specifications</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Missing data points</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="30"/>
                <count group_id="B2" value="32"/>
                <count group_id="B3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <population>Missing data points</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="30"/>
                <count group_id="B2" value="32"/>
                <count group_id="B3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>State</title>
          <description>State in which the pharmacies were located.</description>
          <units>Pharmacy</units>
          <param>Count of Units</param>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="58"/>
                <count group_id="B2" value="62"/>
                <count group_id="B3" value="120"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="30"/>
                <count group_id="B2" value="32"/>
                <count group_id="B3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Alabama</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>California</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Daily prescription volume</title>
          <population>The unit of analysis is pharmacy</population>
          <units>prescriptions per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="27"/>
                <count group_id="B2" value="25"/>
                <count group_id="B3" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="155" spread="100"/>
                    <measurement group_id="B2" value="229" spread="124"/>
                    <measurement group_id="B3" value="192" spread="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of pharmacists trained in vaccine administration</title>
          <population>The unit of analysis is pharmacy</population>
          <units>pharmacists</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="27"/>
                <count group_id="B2" value="25"/>
                <count group_id="B3" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.1" spread="1.5"/>
                    <measurement group_id="B2" value="2.3" spread="0.7"/>
                    <measurement group_id="B3" value="2.3" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Annual pneumococcal polysaccharide (PPSV23)</title>
          <description>Self-reported vaccine dose for pneumococcal polysaccharide (PPSV23) in 2015</description>
          <population>Some pharmacies didn't provide vaccine doses</population>
          <units>doses</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="27"/>
                <count group_id="B2" value="25"/>
                <count group_id="B3" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.60" spread="12.61"/>
                    <measurement group_id="B2" value="3.42" spread="5.58"/>
                    <measurement group_id="B3" value="5.56" spread="9.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Annual pneumococcal 13-valent conjugate (PCV13)</title>
          <description>Self-reported vaccine doses for pneumococcal 13-valent conjugate (PCV13) in 2015</description>
          <population>Some pharmacies didn't provide vaccine doses</population>
          <units>doses</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="27"/>
                <count group_id="B2" value="25"/>
                <count group_id="B3" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18.45" spread="26.82"/>
                    <measurement group_id="B2" value="27.16" spread="54.90"/>
                    <measurement group_id="B3" value="22.69" spread="42.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Annual herpes zoster</title>
          <description>Self-reported vaccine doses for herpes zoster vaccine in 2015</description>
          <population>Some pharmacies didn't provide vaccine doses</population>
          <units>doses</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="46"/>
                <count group_id="B2" value="47"/>
                <count group_id="B3" value="93"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="B1" value="27"/>
                <count group_id="B2" value="25"/>
                <count group_id="B3" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.90" spread="16.71"/>
                    <measurement group_id="B2" value="24.11" spread="28.41"/>
                    <measurement group_id="B3" value="19.38" spread="23.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Herpes Zoster and Pneumococcal Vaccinations Administered</title>
        <description>The change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy during the 6-month intervention period from the 6-month baseline.</description>
        <time_frame>6 months</time_frame>
        <population>The data was reported by the pharmacy unit; participants are part of the pharmacy unit.</population>
        <group_list>
          <group group_id="O1">
            <title>Enhanced Immunization Delivery Model</title>
            <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.
Enhanced immunization delivery model: Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
          </group>
          <group group_id="O2">
            <title>Immunization Update</title>
            <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Herpes Zoster and Pneumococcal Vaccinations Administered</title>
          <description>The change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy during the 6-month intervention period from the 6-month baseline.</description>
          <population>The data was reported by the pharmacy unit; participants are part of the pharmacy unit.</population>
          <units>vaccine doses</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change in the total number of vaccine doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.50" lower_limit="-1" upper_limit="15.25"/>
                    <measurement group_id="O2" value="1" lower_limit="-18" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change in the number of herpes zoster</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.50" lower_limit="-5" upper_limit="7"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change in the number of pneumococcal vaccine doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="-.25" upper_limit="9.5"/>
                    <measurement group_id="O2" value="0" lower_limit="-6" upper_limit="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.202</p_value>
            <p_value_desc>A priori alpha = 0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Strategies Implemented to Promote Immunization Activities</title>
        <description>During the study, pharmacist-technician pairs engaged in on-going strategies used to advertise, market and assess non-seasonal immunization service processes. Of the total of 10 strategies possible, each pair selected strategies that they implemented. Results were reported by a representative from each pharmacy unit.</description>
        <time_frame>6 months</time_frame>
        <population>The unit of analysis was the pharmacy, a representative of each pharmacy unit reported the outcome. Two of the enhanced pharmacy did not provide responses regarding strategies to promote immunization activities.</population>
        <group_list>
          <group group_id="O1">
            <title>Enhanced Immunization Delivery Model</title>
            <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.
Enhanced immunization delivery model: Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
          </group>
          <group group_id="O2">
            <title>Immunization Update</title>
            <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Strategies Implemented to Promote Immunization Activities</title>
          <description>During the study, pharmacist-technician pairs engaged in on-going strategies used to advertise, market and assess non-seasonal immunization service processes. Of the total of 10 strategies possible, each pair selected strategies that they implemented. Results were reported by a representative from each pharmacy unit.</description>
          <population>The unit of analysis was the pharmacy, a representative of each pharmacy unit reported the outcome. Two of the enhanced pharmacy did not provide responses regarding strategies to promote immunization activities.</population>
          <units>Process activities engaged</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="7" upper_limit="9.5"/>
                    <measurement group_id="O2" value="7" lower_limit="5" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.048</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>The Level of Sustainability of Immunization Services</title>
        <description>Change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy from 12 Months Pre- to 12 Months Post-Intervention. A representative of each pharmacy unit reported vaccine doses.</description>
        <time_frame>24 months</time_frame>
        <population>The unit of analysis was the pharmacy. A representative from each pharmacy unit reported the results. Results presented were collected 12 months after the intervention ended. Not all pharmacies that completed the 6 months survey completed the 12 months survey.</population>
        <group_list>
          <group group_id="O1">
            <title>Enhanced Immunization Delivery Model</title>
            <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.
Enhanced immunization delivery model: Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
          </group>
          <group group_id="O2">
            <title>Immunization Update</title>
            <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
          </group>
        </group_list>
        <measure>
          <title>The Level of Sustainability of Immunization Services</title>
          <description>Change in the number of pneumococcal and herpes zoster vaccinations administered in pharmacy from 12 Months Pre- to 12 Months Post-Intervention. A representative of each pharmacy unit reported vaccine doses.</description>
          <population>The unit of analysis was the pharmacy. A representative from each pharmacy unit reported the results. Results presented were collected 12 months after the intervention ended. Not all pharmacies that completed the 6 months survey completed the 12 months survey.</population>
          <units>vaccine doses</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Pharmacy</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Pharmacy</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change in the number of total vaccine doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="3" upper_limit="32.5"/>
                    <measurement group_id="O2" value="8" lower_limit="-6" upper_limit="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change in the number of herpes zoster vaccine dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="-5" upper_limit="12"/>
                    <measurement group_id="O2" value="5" lower_limit="-4" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change in the number of pneumococcal vaccine doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="1.5" upper_limit="19"/>
                    <measurement group_id="O2" value="3" lower_limit="-1.5" upper_limit="19.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>=0.322</p_value>
            <p_value_desc>a priori alpha = 0.05</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>No adverse events were monitored during the study period</time_frame>
      <desc>All cause mortality, serious adverse events and others were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Enhanced Immunization Delivery Model</title>
          <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to this arm will receive a) immunization update training, b) training by immunization experts to enhance immunization delivery model and foster practice change at the beginning of 6-month and c) regular feedback and clinical support for the period of 6 months.
Enhanced immunization delivery model: Webinar and online training will be delivered to intervention pharmacist-technician pairs to discuss strategies that can be used to enhance immunization delivery model and how to integrate the new model into their routine practice. This intervention also includes feedback from immunization experts for the period of 6 months.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
        </group>
        <group group_id="E2">
          <title>Immunization Update</title>
          <description>Pharmacist-technician pairs employed by community pharmacies that are assigned to the control arm will receive an immunization update training. They will not receive a training by immunization experts nor regular feedback and clinical support.
Immunization update: Basic immunization update online webinar will summarize changes in immunization schedules.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Salisa Westrick</name_or_title>
      <organization>Auburn University</organization>
      <phone>3348448314</phone>
      <email>westrsc@auburn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

